Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Remission of Severe Myasthenia Gravis After Massive-Dose Vitamin D Treatment.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Multiple sclerosis: Insights into pathophysiology and novel therapeutic avenues.
MicroRNA-145 as one negative regulator of astrogliosis.
Microsurgical Pontine Descending Tractotomy in Cases of Intractable Trigeminal Neuralgia.
Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.
A metabonomics investigation of multiple sclerosis by nuclear magnetic resonance.
Vitamin d assays: past and present debates, difficulties, and developments.
Available evidence and outcome of off-label use of rituximab in clinical practice.
Natural killer cells in human autoimmune disorders.
Early onset (childhood) monogenic neuropathies.
MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Off-pump coronary surgery in a patient with multiple sclerosis.
Genetic associations with brain cortical thickness in multiple sclerosis.
MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity.
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab.
Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse.
The best clinical paper on multiple sclerosis in 2014: Herodotus and Chataway - Commentary.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.
Mode of action and clinical studies with alemtuzumab.
Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3.
Audiological evidence of therapeutic effect of steroid treatment in neuromyelitis optica with hearing loss.

Pages